SERIES

Oncology Approval News

Decoding global drug approvals with an independent perspective

---

Weekly updates of global oncology drug approvals — not just headline news, but deep analysis of why each approval matters and its clinical/market implications. Includes the original MyThought commentary from Morning Glory Sciences.

📋 Reading Path

1. 2025 Q1: First Quarter Approvals
2. 2025 Q2: Second Quarter Approvals
3. 2025 Q3: Third Quarter Approvals
4. 2025 Q4: Fourth Quarter Approvals
5. Recent: Monthly Archive

📚 All Articles in This Series

→ View all articles

🔗 Related Series

Bispecific Antibody Series / ADC (Antibody-Drug Conjugate) Series / CAR-T Series / KRAS Deep Dive